Introduction
In 1968, Corsellis et al first described limbic encephalitis in association with bronchial carcinoma. 1 Since then, limbic encephalitis has been a well-recognised paraneoplastic syndrome. However, it was only in 2007 that a type of limbic encephalitis was associated with antibodies to N-methyl-Daspartate. NR 1 /NR 2 subunit heterodimers of the N-methyl-Daspartate (NMDA) receptor were identified in a study of 12 women reported by Dalmau J et al. Their findings revealed a 'new category of treatment-responsive paraneoplastic encephalitis'. 2 This same disorder had been identified in 2005 as a separate clinical entity associated with ovarian teratomas. 3 Although classified as 'paraneoplastic' and commonly associated with teratomas, only half of the patients actually have a tumour. 4 Over the last three years, there has been a surge in the number of cases reported with anti-NMDA receptor encephalitis, with over 600 cases reported worldwide and many case series in the neuroscience literature, [5] [6] [7] [8] [9] [10] [11] yet there remains a lack of awareness of this condition among general intensivists. As shown with our patient, most adult patients present to a psychiatrist and are initially misdiagnosed with acute schizophrenia, catatonia, drug abuse, or malingering. 4, 6, 9, 10 It is only after the patient develops seizures, autonomic instability, dyskinesias, hypoventilation or reduced level of consciousness, that a medical review is sought and an organic cause considered. 6 These patients are often referred for intensive care for control of seizures and airway and/or respiratory support. Therefore it is important that intensivists are aware of the disease and include it as a differential diagnosis for patients presenting to the intensive care unit (ICU) with encephalitic symptoms.
Case report
A 19-year-old female with a history of anorexia nervosa two years previously, was admitted from a psychiatric hospital with respiratory distress in an unresponsive, catatonic state. She had been treated in the psychiatric hospital for the preceding 10 days for acute psychotic depression. On arrival, she was obtunded. She had a pyrexia of 37.8°C and was hypoxic (SpO 2 77% on 15 litres oxygen via a non re-breathing mask) but haemodynamic parameters were stable. On examination, she was warm and well perfused with widespread crepitations in both lung fields on auscultation. On neurological examination, her Glasgow Coma Scale score was 11, with rigid limbs and no signs of meningism. Her initial investigations revealed type 1 respiratory failure with a PaO 2 of 6 kPa on the arterial blood gas on 15 L/min of oxygen. Blood tests showed an inflammatory response with a leucocytosis of 27 × 10 9 /L and a raised C-reactive protein (106 mg/L). However, her admission chest X-ray was clear.
On intubation, vomitus was seen on laryngoscopy. In view of the normal chest X-ray, a CT pulmonary angiogram was performed, which showed bilateral basal pneumonia in keeping with aspiration. A CT scan of her head was normal. Treatment for aspiration pneumonia, meningitis and encephalitis was initiated and the patient was transferred to the ICU.
On day two, further information from the psychiatric hospital revealed that 3-4 weeks previously she had complained to her mother of low mood with intermittent headaches. Two weeks later, she had expressed paranoid beliefs about her boyfriend wanting to kill her, associated with episodes of aggression and agitation. She was admitted to the local hospital where no acute medical illness was found and the patient was discharged with antipsychotic medication after Anti-NMDA receptor encephalitis: an intensive care perspective HR Haththotuwa, L Malhas, A Jagadeeswaran Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis is a recently described autoimmune/paraneoplastic condition that commonly presents with psychiatric symptoms. Often this delays the initial diagnosis until more classical symptoms develop, with seizures, decreased consciousness, dyskinesias, autonomic instability and hypoventilation. As awareness of the condition has grown, the incidence of reported cases has risen. We present a case of a 19-year-old female who was receiving treatment in a psychiatric hospital for psychiatric symptoms and was admitted to the intensive care unit (ICU) with reduced level of consciousness and aspiration pneumonia. She was subsequently diagnosed with anti-NMDA receptor encephalitis. The management and treatment of the case is described and the literature on anti-NMDA receptor encephalitis reviewed, with particular attention to the aspects pertinent to providing intensive care for these patients.
Keywords: NMDA receptor; antibody; encephalitis; psychosis; intensive care review by the psychiatrist. Over the next two days, she had auditory hallucinations of fictional characters, delusional beliefs about being in a storybook, increasing confusion and behavioural changes, eg removing her clothes in public. She was admitted to the psychiatric hospital under a mental health section and was treated for acute psychosis with antipsychotics, anti-depressants and sedatives. Over the next five days in the psychiatric unit, she had become progressively more non-communicative and withdrawn, with occasional bursts of aggression requiring restraint. On day nine of admission, she had become rigid, catatonic, incontinent, dysphagic, uncommunicative and was bedbound. Electroconvulsive therapy was planned. However, on day 11 she was found to be in respiratory distress and was admitted to the emergency department, where she was intubated, mechanically ventilated and transferred to the ICU.
In ICU, she was stable on ventilatory support. Cerebrospinal fluid (CSF) analysis showed likely viral encephalitis (white cell count 26 × 10 9 /L with 100% lymphocytes), with raised intracranial pressure with an opening pressure of 38 cm H 2 O. Initial CSF results on day three were weakly positive for CMV; however, repeat testing was negative. Other viral and bacterial screens were also negative. However, treatment with antimicrobials and antivirals was continued and anti-epileptic medication (phenytoin) was commenced in view of the high risk of seizures.
On day 4 and 5 sedation was paused; the patient remained rigid with eyes open. She demonstrated autonomic instability with the heart rate varying between 60 and 174 beats per minute, pyrexia and dilated pupils. On day six, an MRI scan, MR venogram and angiogram were performed and reported as normal. An auto-antibody and paraneoplastic screen was requested as the emerging pattern of signs together with her presentation was beginning to suggest auto-immune encephalitis. In view of the association of anti-NMDA receptor encephalitis with ovarian teratomas, an ultrasound scan of her abdomen was performed while awaiting results of the antibody screen; however, this was normal.
An EEG performed on day eight showed a large amount of generalised delta-wave activity predominantly in the frontal regions, demonstrating significant encephalopathy with no epileptiform activity. However, the patient started to have an increasing frequency of seizures off sedation, associated with hypertension, tachycardia, eye rolling, tongue protrusion and frothing at the mouth. Therefore sedation was continued as doses of anti-epileptics (phenytoin and levitiracetam) were titrated upwards. On day 10, a tracheostomy was inserted in view of the protracted weaning process due to her reduced conscious level.
On day 13 of admission, her NMDA receptor antibody test came back positive and a five-day course of IV methylprednisolone was started. However, there was no improvement in haemodynamics, consciousness level, purposeful movements or seizures. On day five of treatment with steroids, she had a seizure lasting 50 minutes, which was eventually controlled with a thiopentone infusion. On day 18 as the steroids were stopped she was started on a five day course of IV immunoglobulin (0.4 g/kg/day). By the last two days of her immunoglobulin course, she improved, with reduced frequency of seizures as sedation was withdrawn. Repeat EEGs showed no signs of epileptiform activity. On day 24, a whole-body CT scan was done to look for teratomas, which was reported as normal apart from a functional cyst in the left ovary. This was discussed with the gynaecologists who felt that it was benign. The case was also discussed with the neuroradiologists at a tertiary centre. A PET scan was not advised.
As her sedation was weaned she started to demonstrate orofacial dyskinesias and twitches and on day 28 she had two short runs of asystole. Over the next few days, she improved and by day 31 she was beginning to mouth words and obey commands, interspersed with periods of agitation. On day 37, the tracheostomy was replaced with a mini-tracheostomy. On day 42, her anti-epileptics were weaned, but she was continued on levetiracetam. On day 49, we were able to remove her mini tracheostomy; her dyskinesias had stopped, and she was obeying commands and beginning to communicate. On the 55th day from admission, she was speaking in short sentences, started a light diet and was discharged to the ward the following day for further rehabilitation.
Discussion
In this case, the patient presented with psychiatric symptoms and went on to develop fronto-striatal syndrome, autonomic instability and seizures. She was supported with mechanical ventilation and seizure control with anti-epileptics, ultimately requiring thiopentone. After a positive NMDA receptor antibody test, she was treated with steroids and immunosuppression. The CT and MRI of her brain were normal, as in 50% of patients. 4, 9 No underlying teratoma or other malignancy was identified. As suggested in previously reported cases, this means our patient has a higher chance of relapse and means she will require surveillance in case this event precedes the ability to identify a teratoma. She currently is undergoing neuro-rehabilitation, showing good progress.
However, she was only diagnosed 26 days after she first sought medical attention and 40 days from presentation with the initial symptoms. Diagnosis was expedited by the fact that she aspirated. If she had not, diagnosis could have been further delayed. Early recognition and treatment of this condition is vital, as it is a potentially fatal, nevertheless reversible condition.
Presentation and aetiology
Anti-NMDA receptor encephalitis most commonly affects women (80%) with a median age of 23 years. 4, 7 However, in a case series reported in 2009, of 81 patients under the age of 18 years, 40% were children with a median age of 14 years. 8 A well-defined set of clinical characteristics is associated with this syndrome, which is often preceded by a viral-like illness. 4 In the case series analysis of 100 patients by Dalmau et al, all patients presented with psychiatric symptoms or memory problems and most patients had seizures, decreased consciousness, dyskinesias, autonomic instability and hypoventilation, with 88% of patients requiring intensive care support. 4, 11 These symptoms can be explained by NMDA receptor hypofunction. The reduction in NMDA receptor activity results in inactivation of GABAergic neurones, resulting in disinhibition of excitatory pathways and a fronto-striatal syndrome which manifests as psychosis, catatonia, mutism, rigidity and dystonia. Its effect on the brainstem results in semi-rhythmic limb, trunk and bulbar movements. Autonomic instability, with hyperthermia, hypoventilation, blood pressure fluctuations, tachycardia, bradycardia, constipation or ileus is a result of the involvement of the dopaminergic, noradrenergic and cholinergic systems. 4, 6 Hypoventilation is secondary to NMDA receptor hypofunction at the pontine-medullary respiratory network level. 4 The presentation of this case fits the classical presentation, with neuropsychiatric symptoms preceding a movement disorder, dysautonomia, gaze deviation and decreased level of consciousness. The latter symptoms often manifest 10 to 20 days after the onset of the initial neuropsychiatric symptoms. 10 Some patients may also have a viral-like prodrome of headache and fever. 10, 12 Investigations When a patient presents with reduced consciousness, psychosis and behavioural disturbance, encephalitis of any cause would be part of the differential diagnosis. 8 It is important to screen for other causes of encephalitis and disturbed mentation, eg viral, bacterial and vasculitic causes. Therefore, after routine blood tests, a CT head scan, followed by a lumbar puncture for cerebrospinal fluid analysis should be performed. Unfortunately, initial investigations including MRI and EEG may be normal. 13 This was perhaps the case in our patient who had investigations performed at another hospital when symptoms first emerged with psychosis and behavioural change. Therefore it is important to have this differential diagnosis in mind, to test for the antibody and consider repeating investigations.
The diagnostic test is a serum or CSF analysis for the NMDA receptor antibody; a positive test confirms the diagnosis. The antibody levels usually correlate with disease activity, 4 levels being high at presentation or at the beginning of treatment and tapering off as the patient improves clinically. 10 With anti-NMDA receptor encephalitis, characteristically the CSF analysis would show an elevated lymphocyte count, a normal or mildly raised protein level with oligo-clonal bands in 60% of the patients. 4, 9 Magnetic resonance imaging of the brain can be normal in 50% of the cases. If abnormal, it usually shows increased signals in the FLAIR and T2 sequence in the cerebral, cerebellar or medial temporal lobes. 4, 11 The EEG can be normal or show slow delta wave activity, representing encephalopathy. Occasionally, ictal activity is found on EEG but patients often have movement disorders in the form of dyskinesias, which are misinterpreted clinically as seizures. 4, 11 When the diagnosis of NMDA receptor antibody is suspected, a clinical and imaging evaluation to look for underlying tumours should be undertaken while awaiting antibody results. Ultrasound scan of the pelvis in female patients would be the initial imaging modality to look for teratomas of the ovary. It is found in approximately 50% of women over the age of 18 years and less frequently in children (31%). 4, 8, 11 Other tumours that have been associated with this condition include teratomas of the testicle and mediastinum, Hodgkin' s lymphoma, sex cord-stromal tumours and small-cell lung cancer. 10 Whole-body CT, MRI and PET scans to look for other tumours should be performed if the antibody test is positive, if ultrasound scanning is negative or inconclusive. In our case, no underlying malignancy was found.
Management
The definitive management is immunosuppression with steroids followed by immunoglobulins or plasma exchange, and identifying and removing the underlying tumour. Patients with delayed diagnosis, with no tumour identified or tumours not removed, often relapse or fail to improve on initial immunosuppression and require further treatment. 4, 10 Second-line immunosuppression includes rituximab or cyclophosphamide, or both. On occasion, long-term immunosuppression will be needed. 4, 10 Annual tumour surveillance for at least two years is required in view of the possibilities of tumour recurrence or of the encephalitis preceding the onset of tumour. 8 While definitive treatment as outlined above is initiated or takes effect, patients require supportive care with the involvement of a multi-disciplinary team. Most patients initially seek psychiatric help during the psychotic and behavioural phase and require treatment to control their thoughts and actions for the safety of themselves and others. 4, 6, 9, 10 Intensivists will encounter these patients later in the disease process as hypoventilation, coma, uncontrolled seizures and autonomic instability develop. Intensivists need to support the patient with mechanical ventilation and seizure control with anti-epileptics and induced coma. It is vital to be able to differentiate between movement disorders and seizures which will avoid over-and under-use of anti-epileptics and sedatives. 8 Anti-epileptics and sedatives should be withdrawn gradually as the patient improves.
Patients will have autonomic disturbance with fluctuating heart rate, blood pressure and temperature. It is important to realise that this is part of the condition, which will improve as definitive treatment takes effect. Therefore, avoid unnecessary use of antimicrobial agents unless a source of sepsis is identified and treat specific physiological parameters if they are persistent or cause significant compromise. Our patient had extreme variations in heart rate and blood pressure, and had intermittent hyperthermia with no source of sepsis. We treated tachycardia with a beta-blocker (propranolol) but on occasion she became bradycardic and had two short runs of asystole which did not recur and the propranolol was discontinued. Once she was treated with immunosuppression her physiology normalised. Of note, there have been cases where patients have required temporary or permanent pacing for prolonged cardiac pauses. 7, 14 With the case we present, the asystolic events were likely to be compounded by the beta-blockade since no more were seen on its cessation.
As patients improve they will require a period of rehabilitation with physiotherapy, occupational therapy and speech and language therapist input. 8
Outcome
As patients gradually improve on treatment, their ventilation improves, autonomic function stabilises followed by reduction in seizure activity and dyskinetic movements. There will be a period of psychosis and agitation prior to regaining the ability to obey commands and converse. Therefore the pattern of recovery is almost in the reverse order to that of the presenting symptoms. 7 There is a good outcome from the disease especially if immunosuppression is initiated early and if a tumour is identified and removed. Patients with identified tumours do better than those without and those who have had both tumour resection and immunotherapy do better than those that had either treatment. 4, 8, 10 In a case series of 360 patients with a six-month follow-up, 15 patients died (4%), 14 of them in the ICU. Causes of death included sepsis, cardiac arrest, acute respiratory distress, status epilepticus, tumour progression, withdrawal of medical support and one patient died of an unknown cause. 7 In another case series of 100 patients with a seventeen-month follow-up, seven patients died due to the disease process while 47 patients made full recovery with no neurological or behavioural sequelae. 4, 11 Patients often require hospitalisation in an acute facility for three to four months followed by several months of rehabilitation. 7, 8 
Conclusion
Anti-NMDA receptor encephalitis, although a relatively newly identified condition is quite common, with a recognisable pattern of presentation, which unfortunately mimics both psychiatric and infective disease processes. With the markedly different treatments required (immunosuppression rather than antimicrobials or anti-psychotics) it is important to include it in the differential diagnosis of patients presenting in such a manner to ICU.
